Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farlow, M. R.
Right arrow Articles by Ghetti, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farlow, M. R.
Right arrow Articles by Ghetti, B.
NEUROLOGY 1989;39:1446
© 1989 American Academy of Neurology

Gerstmann-Sträussler-Scheinker disease. I. Extending the clinical spectrum

M. R. Farlow, MD, R. D. Yee, MD, S. R. Dlouhy, PhD, P. M. Conneally, PhD, B. Azzarelli, MD and B. Ghetti, MD

From the Departments of Neurology, Medical Genetics, Ophthalmology, and Pathology (Division of Neuropathology), Indiana University School of Medicine, Indianapolis, IN.

We present the clinical findings in affected members of a large kindred with Gerstmann-Sträussler-Scheinker disease. Sixty-four patients exhibited progressive ataxia, dementia, and parkinsonian features. Inheritance appears to be autosomal dominant. Impaired smooth-pursuit eye movements, defective short-term memory, clumsiness of the hands, and ataxia of gait develop in the late 30s to early 60s. Eye movement abnormalities are characteristic of cerebellar dysfunction. Dementia progresses gradually over several years. Later, rigidity and bradykinesia appear and, at this stage, there is often psychosis or severe depression with rapid weight loss. Death occurs in 6 months to 2 years after onset of rigidity. Magnetic resonance imaging in 2 affected individuals showed cerebellar atrophy. There is decreased T2 signal in the basal ganglia, consistent with iron deposition.

Address correspondence and reprint requests to Dr. Farlow, Department of Neurology, Indiana University School of Medicine, Emerson Hall, Room 125, 545 Barnhill Drive, Indianapolis, IN 46202–5124.

Neuro-ophthalmologic studies were supported in part by an unrestricted research grant from Research to Prevent Blindness, Inc. (Dr. R.D. Yee).

Received August 11, 1988. Accepted for publication in final form May 25, 1989.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
P. Piccardo, J. J. Liepnieks, A. William, S. R. Dlouhy, M. R. Farlow, K. Young, D. Nochlin, T. D. Bird, R. R. Nixon, M. J. Ball, et al.
Prion Proteins with Different Conformations Accumulate in Gerstmann-Straussler-Scheinker Disease Caused by A117V and F198S Mutations
Am. J. Pathol., June 1, 2001; 158(6): 2201 - 2207.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Tranchant, N Sergeant, A Wattez, M Mohr, J M Warter, and A Delacourte
Neurofibrillary tangles in Gerstmann-Straussler-Scheinker syndrome with the A117V prion gene mutation
J. Neurol. Neurosurg. Psychiatry, August 1, 1997; 63(2): 240 - 246.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Prusiner
Molecular biology of prion diseases
Science, June 14, 1991; 252(5012): 1515 - 1522.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.